Breaking News Instant updates and real-time market news.

WLK

Westlake Chemical

$61.04

(0.00%)

09:40
05/13/19
05/13
09:40
05/13/19
09:40

Westlake Chemical price target lowered to $62 from $76 at RBC Capital

RBC Capital analyst Arun Viswanathan lowered his price target on Westlake Chemical to $62 and kept his Sector Perform rating after its Q1 earnings miss, with a "muted" outlook for its PVC prices and caustic demand also expected to weigh on its Q2. The analyst notes that he would only get more constructive on Westlake Chemical on signs of improvement in demand and resolution of trade issues.

  • 17

    May

WLK Westlake Chemical
$61.04

(0.00%)

03/21/19
LEHM
03/21/19
NO CHANGE
Target $82
LEHM
Overweight
Westlake Chemical price target lowered to $82 from $90 at Barclays
Barclays analyst Michael Leithead raised his price target for Westlake Chemical to $82 from $90 while keeping an Overweight rating on the shares. The analyst believes Street estimates are too high primarily in Vinyls, driven by continued caustic soda decline and further headwinds from high-cost natural gas inventory. He sees these offsetting PVC price improvements and modest seasonal benefits in building products. However, the analyst cites tightening Chlor-alkali supply/demand fundamentals, above-average capital deployment, and Westlake's "supportive valuation" for his continued positive view.
04/15/19
NOMU
04/15/19
UPGRADE
Target $79
NOMU
Neutral
Westlake Chemical upgraded to Neutral from Reduce at Nomura Instinet
Nomura Instinet analyst Aleksey Yefremov upgraded Westlake Chemical to Neutral from Reduce and raised his price target for the shares to $79 from $70.
04/15/19
NOMU
04/15/19
UPGRADE
NOMU
Nomura Instinet upgrades six in Chemicals ahead of Q1 earnings
Nomura Instinet analyst Aleksey Yefremov upgraded six names in Cyclical Chemicals ahead of the Q1 reporting season. The analyst sees the valuations as "encouraging" versus more defensive chemicals and the broader market. Select commodity prices are confirming better macro data, but large supply additions "are a limiting factor on how high stocks can go," Yefremov tells investors in a research note. China macro data continued to improve recently and valuations for the six upgrades are below cycle-average, says the analyst. He upgraded to Buy from Neutral shares of Dow Inc. (DOW), Eastman Chemical (EMN), Huntsman (HUN) and LyondellBasell (LYB) and to Neutral from Sell shares of Westlake Chemical (WLK) and Olin (OLN).
04/15/19
04/15/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Neutral from Sell at BTIG with analyst Richard Greenfield saying the rating change was prompted more by the commentary from CEO Bob Iger on CNBC than by the company's investor day presentation unveiling Disney+. 2. Western Digital (WDC) upgraded to Buy from Neutral at Longbow with analyst Nikolay Todorov saying NAND fundamentals are bottoming and "there is a line of sight to cyclical recovery." 3. Dow Inc. (DOW), Huntsman (HUN), LyondellBasell (LYB), and Eastman Chemical (EMN) upgraded to Buy from Neutral at Nomura Instinet, while Olin (OLN) and Westlake Chemical (WLK) were upgraded to Neutral from Reduce. 4. Waste Management (WM) upgraded to Buy from Hold at Stifel with analyst Michael Hoffman saying even with potential divestitures to get the deal approved, adding Advanced Disposal "dramatically lowers" Waste Management's cost of capital, reduces capital spending, converts more of the fleet to CNG, and stimulates tuck-in activity that should all drive sustainable free cash flow growth. 5. Sony (SNE) upgraded to Buy from Hold at Jefferies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

TGT

Target

$84.20

1.67 (2.02%)

07:04
08/19/19
08/19
07:04
08/19/19
07:04
Hot Stocks
Target announces launch of Food & Beverage brand 'Good & Gather' »

Target announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

07:04
08/19/19
08/19
07:04
08/19/19
07:04
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

ETON

Eton Pharmaceuticals

$5.69

0.095 (1.70%)

07:04
08/19/19
08/19
07:04
08/19/19
07:04
Hot Stocks
Eton Pharmaceuticals announces results from bioequivalence studies of ET-104 »

Eton Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Mar

MDT

Medtronic

$102.73

0.98 (0.96%)

07:03
08/19/19
08/19
07:03
08/19/19
07:03
Recommendations
Medtronic analyst commentary  »

Medtronic price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 04

    Sep

  • 09

    Sep

TRLFF

True Leaf Medicine

$0.00

(0.00%)

07:03
08/19/19
08/19
07:03
08/19/19
07:03
Hot Stocks
True Leaf submits site evidence package to Health Canada for True Leaf Campus »

True Leaf Cannabis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$15.21

0.3 (2.01%)

07:03
08/19/19
08/19
07:03
08/19/19
07:03
Hot Stocks
Vanda Pharmaceuticals receives CRL from FDA on sNDA for HETLIOZ »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PROS

ProSight

$18.71

-0.5 (-2.60%)

07:01
08/19/19
08/19
07:01
08/19/19
07:01
Initiation
ProSight initiated  »

ProSight initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULC

Fulcrum Therapeutics

$9.11

-0.14 (-1.51%)

07:01
08/19/19
08/19
07:01
08/19/19
07:01
Hot Stocks
Fulcrum Therapeutics intitiates Phase 2b clinical trial of losmapimod for FSHD »

Fulcrum Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DELL

Dell Technologies

$48.46

1.55 (3.30%)

06:59
08/19/19
08/19
06:59
08/19/19
06:59
Recommendations
Dell Technologies analyst commentary  »

Dell Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

APTS

Preferred Apartment

$14.32

0.165 (1.17%)

06:59
08/19/19
08/19
06:59
08/19/19
06:59
Hot Stocks
Preferred Apartment makes joint venture investment in Virginia shopping center »

Preferred Apartment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PROS

ProSight

$18.71

-0.5 (-2.60%)

06:58
08/19/19
08/19
06:58
08/19/19
06:58
Initiation
ProSight initiated  »

ProSight initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$5.05

0.665 (15.18%)

06:58
08/19/19
08/19
06:58
08/19/19
06:58
Hot Stocks
Tailored Brands reaffirms Q2 SSS outlook »

The company expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 23

    Sep

ACM

Aecom

$32.97

0.53 (1.63%)

06:56
08/19/19
08/19
06:56
08/19/19
06:56
Hot Stocks
Aecom announces extension of tank operations contract »

AECOM announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$179.26

3.89 (2.22%)

06:55
08/19/19
08/19
06:55
08/19/19
06:55
Hot Stocks
Estee Lauder sees 'strong consumer demand for high-quality products' in FY20 »

"The company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

TLRD

Tailored Brands

$5.05

0.665 (15.18%)

06:52
08/19/19
08/19
06:52
08/19/19
06:52
Earnings
Tailored Brands raises Q2 adjusted EPS view to 78c-80c from 65c-70c »

Q2 consensus 70c. Sees Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 23

    Sep

DRYS

DryShips

$3.83

0.065 (1.73%)

06:50
08/19/19
08/19
06:50
08/19/19
06:50
Hot Stocks
DryShips to be acquired by SPII Holdings for $5.25 per share in cash »

DryShips announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$5.05

0.665 (15.18%)

06:50
08/19/19
08/19
06:50
08/19/19
06:50
Earnings
Tailored Brands announces sale of corporate apparel business for $62M in cash »

Tailored Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 23

    Sep

DRYS

DryShips

$3.83

0.065 (1.73%)

06:49
08/19/19
08/19
06:49
08/19/19
06:49
Hot Stocks
Breaking Hot Stocks news story on DryShips »

DryShips to be acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDAY

Ceridian

$50.69

0.2 (0.40%)

06:49
08/19/19
08/19
06:49
08/19/19
06:49
Upgrade
Ceridian rating change  »

Ceridian upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

DECK

Deckers Brands

$134.33

1.39 (1.05%)

06:49
08/19/19
08/19
06:49
08/19/19
06:49
Upgrade
Deckers Brands rating change  »

Deckers Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

  • 25

    Sep

EL

Estee Lauder

$179.26

3.89 (2.22%)

06:48
08/19/19
08/19
06:48
08/19/19
06:48
Earnings
Estee Lauder sees FY20 adjusted EPS $5.90-$5.98, consensus $5.81 »

Reported net sales are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

EL

Estee Lauder

$179.26

3.89 (2.22%)

06:47
08/19/19
08/19
06:47
08/19/19
06:47
Earnings
Estee Lauder sees Q1 adjusted EPS $1.56-$1.59, consensus $1.55 »

Reported net sales are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

EL

Estee Lauder

$179.26

3.89 (2.22%)

06:45
08/19/19
08/19
06:45
08/19/19
06:45
Earnings
Estee Lauder reports Q4 EPS 64c, consensus 53c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

BAC

Bank of America

$27.04

0.79 (3.01%)

, C

Citi

$63.46

2.13 (3.47%)

06:45
08/19/19
08/19
06:45
08/19/19
06:45
Periodicals
Updated Volcker Rule expected this week, WSJ reports »

An updated Volcker Rule…

BAC

Bank of America

$27.04

0.79 (3.01%)

C

Citi

$63.46

2.13 (3.47%)

JPM

JPMorgan

$107.73

2.52 (2.40%)

USB

U.S. Bancorp

$52.25

0.99 (1.93%)

WFC

Wells Fargo

$44.40

1.01 (2.33%)

GS

Goldman Sachs

$199.39

3.2 (1.63%)

MS

Morgan Stanley

$39.94

0.85 (2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 06

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 16

    Oct

  • 27

    Oct

PCG

PG&E

$14.30

-0.08 (-0.56%)

06:44
08/19/19
08/19
06:44
08/19/19
06:44
Periodicals
PG&E holds on to sole rights to devise chapter 11 exit plan, WSJ reports »

A U.S. Bankruptcy Court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.